Orange Book product · Generic (ANDA)
CYANOCOBALAMIN
CYANOCOBALAMIN
At a glance
Jun 30, 2023
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 30, 2023
3 yr ago
Today
Pharmaceutical detail
Active ingredient
CYANOCOBALAMIN
Strength
0.5MG/SPRAY
Dosage form
SPRAY, METERED
Route
NASAL
TE code
AB
Application
ANDA 210629
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CYANOCOBALAMIN
- 2007CALOMISTBrand (NDA)
NDA 022102 · PH HEALTH
- 2005NASCOBALBrand (NDA)
NDA 021642 · ENDO OPERATIONS
- 1996NASCOBALBrand (NDA)
NDA 019722 · ENDO OPERATIONS
- —BERUBIGENBrand (NDA)
NDA 006798 · PHARMACIA AND UPJOHN
- —CYANOCOBALAMINBrand (NDA)
NDA 007085 · WARNER CHILCOTT
- —REDISOLBrand (NDA)
NDA 006668 · MERCK
- —RUBIVITEBrand (NDA)
NDA 010791 · BEL MAR
- —RUBRAMIN PCBrand (NDA)
NDA 006799 · BRISTOL MYERS SQUIBB
- —VI-TWELBrand (NDA)
NDA 007012 · BAYER HLTHCARE
- 2024CYANOCOBALAMINGeneric (ANDA)
ANDA 214316 · MEITHEAL
- 2024CYANOCOBALAMINGeneric (ANDA)
ANDA 217839 · MANKIND PHARMA
- 2022CYANOCOBALAMINGeneric (ANDA)
ANDA 215107 · SAGENT PHARMS INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
